$ACH News

Accendra Health (ACH) Price Target Increased by 28.92% to 4.27

Accendra Health, Inc. 2026 Q1 - Results - Earnings Call Presentation

Accendra Health, Inc. (ACH) Shareholder/Analyst Call Prepared Remarks Transcript

UBS Maintains Neutral on Accendra Health, Raises Price Target to $4.5

Citigroup Maintains Buy on Accendra Health, Raises Price Target to $5

Baird Maintains Outperform on Accendra Health, Raises Price Target to $6

Accendra Health Makes Progress Addressing Its Debt Load

Accendra Health, Inc. (ACH) Q1 2026 Earnings Call Transcript

Accendra Health (NYSE:ACH) Beats Q1 Estimates and Unveils $1.5B Debt Restructuring

Accendra Health Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.590B Est

Accendra Health, Inc. 2025 Q4 - Results - Earnings Call Presentation

Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32

Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade)

Leerink Partners Maintains Market Perform on Accendra Health, Lowers Price Target to $2.75

Accendra Health Inc (NYSE:ACH) Reports Q4 2025 Earnings Miss and Provides 2026 Outlook

Accendra Health, Inc. (ACH) Q4 2025 Earnings Call Transcript

Accendra Health Sees FY2026 Sales $2.550B-$2.650B vs $2.604B Est

Accendra Health, Inc. Common Stock Q4 Adj. EPS $0.21 Misses $0.22 Estimate, Sales $708.967M Miss $714.733M Estimate

Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77

Citigroup Maintains Buy on Accendra Health, Lowers Price Target to $4